|
CALM3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.856440E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.690020E-01 |
| Normal-vs-Stage2 |
7.294600E-01 |
| Normal-vs-Stage3 |
3.436700E-04 |
| Normal-vs-Stage4 |
5.742400E-03 |
| Stage1-vs-Stage2 |
6.761400E-01 |
| Stage1-vs-Stage3 |
6.081200E-03 |
| Stage1-vs-Stage4 |
5.026200E-02 |
| Stage2-vs-Stage3 |
5.556300E-02 |
| Stage2-vs-Stage4 |
9.386000E-02 |
| Stage3-vs-Stage4 |
9.286600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.505760E-02 |
| Normal-vs-AfricanAmerican |
6.792400E-01 |
| Normal-vs-Asian |
5.692200E-01 |
| Caucasian-vs-AfricanAmerican |
8.771700E-02 |
| Caucasian-vs-Asian |
3.085200E-01 |
| AfricanAmerican-vs-Asian |
4.560400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.461400E-03 |
| Normal-vs-Female |
6.611500E-02 |
| Male-vs-Female |
9.083900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.739760E-01 |
| Normal-vs-Age(41-60Yrs) |
3.348400E-02 |
| Normal-vs-Age(61-80Yrs) |
4.743600E-03 |
| Normal-vs-Age(81-100Yrs) |
3.441200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.147800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.627500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.984200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.113400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.880000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.723200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.91494999999264E-05 |
| Classical-VS-Follicular |
3.621800E-01 |
| Classical-VS-Other |
4.550200E-01 |
| Classical-VS-Normal |
3.097800E-02 |
| Tall-VS-Follicular |
8.42200000000792E-05 |
| Tall-VS-Other |
5.734600E-01 |
| Tall-VS-Normal |
2.98340000037811E-07 |
| Follicular-VS-Other |
3.604600E-01 |
| Follicular-VS-Normal |
4.233800E-01 |
| Other-VS-Normal |
2.261600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.771400E-01 |
| Normal-vs-N1 |
6.48290000015983E-07 |
| N0-vs-N1 |
3.89710000003873E-06 |
|
|
